X

Trial Profile

[11C] Sertraline PET Imaging Study That Investigates Pharmacokinetics and Pharmacodynamics of Sertraline After Low Dose Administration.

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 18 Sep 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Sertraline (Primary)
Indications Depressive disorders; Generalised anxiety disorder; Obesity; Obsessive-compulsive disorders; Panic disorder; Post-traumatic stress disorders; Premature ejaculation; Premenstrual dysphoric disorder; Social phobia
Focus Pharmacokinetics
Acronyms SNUH-CPT-SERT

Most Recent Events

25 Aug 2011 New source identified and integrated (Korean Clinical Trials Register; KCT0000022).
11 Jan 2011 Biomarkers information updated
10 Jan 2011 Actual end date (Mar 2010) added as reported by ClinicalTrials.gov.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com